Abstract
The recently discovered Omicron variant of SARS-CoV-2 has rapidly burst into the public and scientific eye, being detected in more than 26 countries around the world. Given its more than 50 mutations, there is widespread concern about its public health impact, leading the World Health Organization to designate it a variant of concern. This Commentary provides a summary of current knowledge and unknowns about this viral variant as of December 2, 2021 and summarizes the key questions that need to be rapidly answered.
| Original language | English (US) |
|---|---|
| Pages (from-to) | e685 |
| Journal | Clinical and Translational Medicine |
| Volume | 11 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2021 |
Bibliographical note
© 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.Keywords
- Angiotensin-Converting Enzyme 2/genetics
- Botswana
- COVID-19/epidemiology
- COVID-19 Vaccines
- Global Health
- Humans
- Mutation
- Netherlands
- Pandemics
- SARS-CoV-2/genetics
- South Africa
- World Health Organization
PubMed: MeSH publication types
- Journal Article
